XML 71 R38.htm IDEA: XBRL DOCUMENT v3.26.1
Share-based payments (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of options granted under each plan

As at December 31, 2024, the options granted and outstanding under each Plan were as follows:

 

The 2021 Plan   619,167 
The 2024 Plan   4,020,750 
The 2024 Plc Plan   704,250 
Schedule of number of shares under option

The 2021 Plan   309,584 
The 2024 Plan   2,010,375 
The 2024 Plc Plan   352,125 
Schedule of options outstanding and exercisable

Information relating to options outstanding and exercisable at December 31, 2025 and 2024 is as follows:

 

Activity  Number of Options   Weighted Avg. Exercise Price   Grant Date Fair Value   Aggregate grant-date fair value   Weighted Avg. Remaining Life 
Outstanding options at Dec 31, 2023   1,107,083     0,001    851,860     849,698     7.9 
Granted   1,885,625     1,179    7,590,933     4,874,513     10.0 
Forfeited   (186,875)    0,001    (76,219)    (76,025)    7.4 
Regranted   476,875     0,169    2,125,883     1,924,636     10.0 
Cancelled   (610,625)    0,001    (496,805)    (495,611)    7.2 
Options outstanding and exercisable at Dec 31, 2024   2,672,083     -   $ 9,995,652    $7,077,211       
Granted   -    -    -    -    - 
Forfeited   -    -    -    -    - 
Regranted   -    -    -    -    - 
Cancelled   -    -    -    -    - 
Options outstanding and exercisable at Dec 31, 2025   2,672,083         $ 9,995,652    $7,077,211       
Schedule of aggregate intrinsic value of options outstanding and exercisable

The aggregate intrinsic value of options outstanding and exercisable as of December 31, 2025 and 2024 was approximately:

 

   2025  2024
Intrinsic value of options outstanding  $1.9 million  $4.2 million
Intrinsic value of options exercisable  $1.9 million  $4.2 million